Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market
Bringing the abstract to the here and now
Extensive research generates high-complexity molecular tools that help physicians execute more informed treatment decisions in clinical practice every day.
Partnering with a range of physicians, from
world-renowned institutions to community clinics.
Biotheranostics brings genomic tools to the fingertips of oncology practices across all clinical settings.
Delivering information for personalized medicine.
Because every patient deserves a customized care plan.
Molecular information helps individualize each patient's treatment.